Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity. [electronic resource]
Producer: 19870909Description: 568-71 p. digitalISSN:- 0006-4971
- Antineoplastic Agents -- antagonists & inhibitors
- Bone Marrow -- drug effects
- Bone Marrow Cells
- Cytarabine -- antagonists & inhibitors
- DNA -- biosynthesis
- Deoxycytidine -- metabolism
- Humans
- Leukemia -- pathology
- Neoplastic Stem Cells -- drug effects
- Phosphates -- metabolism
- Stem Cells -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.